Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

A research group has developed a new COVID-19 testing system using Janus particles -- microparticles with two sides possessing distinctive molecular properties. These particles are engineered to bind ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

In patients with chronic liver disease, including PBC, ursodeoxycholic acid shows promise as an adjunctive therapy for COVID-19 infection.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

Managing Director, CEO and Chairman Simon Madder provides an update on the company, discussing drivers behind FY24 ...

The CACHE (Critical Assessment of Computational Hit-Finding Experiments) Challenge has spurred more new research —this time ...

SEATTLE — Third Avenue in Seattle is slowly getting a facelift. The newest addition is overhead lights that were strung ...